1,155 results on '"de Leval, Laurence"'
Search Results
2. What is new in the classification of peripheral T cell lymphomas?
3. Inducible CXCL12/CXCR4–dependent extramedullary hematopoietic niches in the adrenal gland
4. The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop
5. Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop
6. Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop
7. Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop
8. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop
9. Immune Phenotype-Genotype Associations in Primary Clear Cell Renal Cell Carcinoma and Matched Metastatic Tissue
10. PD1 inhibits PKCθ-dependent phosphorylation of cytoskeleton-related proteins and immune synapse formation
11. Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study
12. Follicular Lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases
13. Nitrogen isotopic composition as a gauge of tumor cell anabolism-to-catabolism ratio
14. HIV infection is associated with compromised tumor microenvironment adaptive immune reactivity in Hodgkin lymphoma
15. A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas
16. Extranodal T- and NK-cell lymphomas
17. Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas
18. Multilevel human secondary lymphoid immune system compartmentalization revealed by complementary imaging approaches
19. Towards a national strategy for digital pathology in Switzerland
20. Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation
21. Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations
22. Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK/T-cell lymphoma
23. Correction to: Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop
24. Correction to: The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop
25. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
26. The cGAS–STING pathway drives type I IFN immunopathology in COVID-19
27. EBV-positive large B-cell lymphoma with an unusual intravascular presentation and associated haemophagocytic syndrome in an HIV-positive patient: report of a case expanding the spectrum of EBV-positive immunodeficiency-associated lymphoproliferative disorders
28. Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1
29. Genetic and phenotypic attributes of splenic marginal zone lymphoma
30. Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial
31. Erratum to: Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization
32. Angioimmunoblastic T-Cell Lymphoma
33. Breast Implant-Associated Malignant Lymphoma
34. CD73 expression in normal, hyperplastic, and neoplastic thyroid: a systematic evaluation revealing CD73 overexpression as a feature of papillary carcinomas
35. Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma
36. Lymph node involvement by enteropathy-like indolent NK-cell proliferation
37. EBV-associated NK and T-cell lymphoid neoplasms
38. Pathology and Molecular Pathogenesis of T-Cell Lymphoma
39. An update on the pathology of extranodal T-cell lymphomas
40. Approach to nodal-based T-cell lymphomas
41. Was gibt es Neues bei der Klassifikation der peripheren T-Zell-Lymphomen?
42. Angioimmunoblastic T‐cell lymphoma and Kaposi sarcoma: A fortuitous collision?
43. Pitfalls in the Diagnosis of Non‐Hodgkin's Lymphomas
44. Daratumumab and venetoclax in combination with chemotherapy provide sustained molecular remission in relapsed/refractory CD19, CD20, and CD22 negative acute B lymphoblastic leukemia with KMT2A-AFF1 transcript
45. Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine
46. Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma
47. Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified
48. Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry
49. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma
50. Angioimmunoblastic T‐cell lymphoma and Kaposi sarcoma: A fortuitous collision?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.